Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-alcoholic steatohepatitis.

Peter L M Jansen1

  • 1Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands. pljansen@amc.uva.nl

European Journal of Gastroenterology & Hepatology
|October 19, 2004
PubMed
Summary

Non-alcoholic steatohepatitis (NASH) is a liver condition often linked to obesity and diabetes. Early detection and management focusing on weight loss and insulin sensitivity are key to preventing severe liver damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration.

Hepatology communications·2021
Same author

Correction to: Targeting the ileal bile salt transporter in the treatment of non‑alcoholic fatty liver disease.

Hepatology international·2021
Same author

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease.

Hepatology international·2021
Same author

Editorial: Systems Biology and Bioinformatics in Gastroenterology and Hepatology.

Frontiers in physiology·2019
Same author

Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model.

PloS one·2019
Same author

Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients.

Hepatology (Baltimore, Md.)·2019

Area of Science:

  • Hepatology and metabolic disease research.
  • Investigating liver pathologies and their systemic links.

Context:

  • Non-alcoholic fatty liver (NAFL) is a precursor to Non-alcoholic steatohepatitis (NASH).
  • NASH is a prevalent condition, particularly in individuals with obesity and type 2 diabetes.
  • NAFL is a primary cause of elevated liver enzymes in the general population.

Purpose:

  • To define Non-alcoholic steatohepatitis (NASH) and its pathological characteristics.
  • To highlight the association between NASH, obesity, and type 2 diabetes.
  • To identify potential therapeutic strategies for NASH.

Summary:

  • Non-alcoholic steatohepatitis (NASH) involves liver steatosis, necroinflammation, and fibrosis, potentially leading to cirrhosis and cancer.
  • The liver in NASH prioritizes lipogenesis over glycogenesis, with insulin resistance playing a critical role.
  • Obesity and type 2 diabetes are significant risk factors for NASH.

Impact:

  • NASH is an underdiagnosed condition with serious long-term health consequences.
  • Understanding NASH pathogenesis is crucial for developing effective treatments.
  • Lifestyle modifications and improved insulin sensitivity represent promising therapeutic avenues for NASH management.

Related Experiment Videos